Related Experiment Video
Updated: Oct 4, 2025

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
Published on: December 9, 2013
COVID-19 vaccines: Considering sex differences in efficacy and safety
Adelaide Jensen1, Masha Stromme2, Shayda Moyassari3
1School of Psychology, University of Ottawa, Canada; Women's Brain Project, Switzerland.
Abstract:
The development of SARS-CoV-2 vaccines represents a significant breakthrough for managing the COVID-19 pandemic. However, their approval process has exposed a crucial limitation in clinical trial reports-that is, a disregard for sex differences in response to vaccines. Historically, males and females have shown different reactions to vaccines of many kinds, which have become apparent with the arrival of COVID-19 vaccines in late-2020. In this article, we review regulatory data from Phase III vaccine trials as well as peer-reviewed reports from vaccines administered to the general population, many of which failed to stratify results by sex. We also discuss the exclusion of pregnant and lactating persons in drug development and the regulatory guidelines for use of COVID-19 vaccines in such populations. We conclude by proposing some questions to stimulate discussion with the intent of advancing the field toward precision medicine.
More Related Videos
Related Concept Videos
Bioequivalence studies: Biowaivers
Sexually Transmitted Infections
Bioavailability Study Design: Healthy Subjects Versus Patients
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Bias in Epidemiological Studies
Vaccinations

